Gene · 64240
NIH grants904
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 904
Download this page as JSON| Grant | Title | ABCG5 papers | Newest fiscal year |
|---|---|---|---|
| R01HL107653 | Cholesterol efflux, CHIP and inflammasome activation | 2 | 2025 |
| R01HL148565 | Clonal Hematopoiesis in the Women's Health Initiative | 2 | 2025 |
| R01HL164409 | High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | 2 | 2025 |
| T32HL007343 | Postdoctoral Training in Arteriosclerosis Research | 2 | 2025 |
| ZIABC005562 | Xenobiotic receptors | 2 | 2025 |
| ZIABC005598 | Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells | 2 | 2025 |
| ZIABC010319 | Structural Basis of Biological Membrane Protein Functions and Drug Resistance | 2 | 2025 |
| ZIABC010830 | Mechanisms of non-classical multidrug resistance in cancer | 2 | 2025 |
| ZICBC010947 | Laboratory of Cancer Biology and Genetics Microscopy Core Facility | 2 | 2025 |
| D43TW010540 | Global Health Emerging Scholars Program | 1 | 2025 |
| I01BX003362 | Genetics of Cardiometabolic Diseases in the VA Population | 1 | 2025 |
| K08CA252635 | PRECISE - a PErsonalized Risk Score for gastrIc CancEr | 1 | 2025 |
| K08HL161448 | Integrating genomic and nongenomic risk for coronary artery disease | 1 | 2025 |
| K23HL151871 | The Impact of Thrombosis and Antithrombotic Therapy on Peripheral Artery Disease | 1 | 2025 |
| P01AG026572 | Perimenopause in Brain Aging and Alzheimer's Disease | 1 | 2025 |
| P01AI063302 | The intersection of innate and adaptive immunity to intracellular pathogens | 1 | 2025 |
| P01AI083214 | Harvard-wide Program on Antibiotic Resistance | 1 | 2025 |
| P01CA096832 | NORMAL & NEOPLASTIC GROWTH IN THE BRAIN | 1 | 2025 |
| P01HL128203 | Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity | 1 | 2025 |
| P01HL131481 | Macrophage Dysfunction in Atherosclerosis and Cardiometabolic Diseases | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64240/grants?page=2